Janane F. Rahbani

Assistant Professor of Medicine- UChicago Hematology/Oncology
@UChicagoHemOnc @uchicago. Beyond the Scale: Tackling Obesity, Conquering Cancer

[Janane F. Rahbani @RahbaniLab]

We are hiring! Great city, great university and a great work environment!!

[University of Chicago Hematology/Oncology @UChicagoHemOnc]

The Rahbani Lab is hiring! They are looking for a post-doc researcher interested in exploring the connection between obesity & cancer, as part of our larger metabolomics infrastructure. Learn more and apply: https://t.co/mKL89rkWPg
EOE/Vet/Disability

[Lawrence Kazak @kazaklab]

For 40+ years, we’ve known how UCP1 drives thermogenesis—but how UCP1-independent pathways are activated remained unknown. Thrilled to share our @Nature paper, led by Faiz Hussain, uncovering this mechanism:
https://t.co/0pJFQPDV9V

[Janane F. Rahbani @RahbaniLab]

@BarbaraLKee @jimmunol Congratulations 🎉

[Janane F. Rahbani @RahbaniLab]

@sung4400 So far so good!

[Janane F. Rahbani @RahbaniLab]

@ktsanov @NatureCancer Congratulations Kal!

[Janane F. Rahbani @RahbaniLab]

@SvenssonLab @annagloyn @StanfordPath @StanfordDRC @StanfordEndo Congratulations!

[Martin Klingenspor @MartinKlingens4]

New PhD opportunity at TUM!

[Kunle Odunsi, MD @KunleOdunsiMD]

I’m proud of @UCCancerCenter’s national ranking in the top 1% and #1 in Illinois. It is a testament to our exceptional patient-centered care and innovative research. We are reshaping the future of cancer care @KunleOdunsiMD #NothingWillStopUs

[Janane F. Rahbani @RahbaniLab]

@ErnstLengyel @KunleOdunsiMD @Nature @OvCa_UChicago Great paper, congrats 👏

[UChicagoCancerCenter @UCCancerCenter]

🔥 Hot off the press: In a new @Nature study, @ErnstLengyel and team show that blocking NNMT in tumor-supporting cells restores immune response & stops ovarian cancer growth, offering a new strategy for hard to treat cancers. @OvCa_UChicago @uchicago_obgyn
https://t.co/h05za6qlG5

[Lawrence Kazak @kazaklab]

New paper from @BunkJakub and Mina Ersin in our lab: CKB is the key creatine kinase driving UCP1-independent #thermogenesis in beige fat via the futile creatine cycle (FCC).

https://t.co/YbR5mtTmSp

@McGillGCI @McGillBiochem @MolMetab

[Lawrence Kazak @kazaklab]

Today in @NatureComms, we show the #FutileCreatineCycle plays a key role in #thermogenesis, independent of UCP1. We also challenge the belief that brown adipocytes lack enough ATP synthase for thermogenesis. Congrats @BunkJakub! Full paper: https://t.co/8kUYDxw6qD @McGillGCI

[Janane F. Rahbani @RahbaniLab]

@GalmozziAndrea @acypess @NatMetabolism @dylan_duerre @UWMadison @uwsmph @uofutah Congratulations!

[Janane F. Rahbani @RahbaniLab]

@AkashPatnaik7 @ASCI @UCCancerCenter @UChicagoHemOnc @PCF_Science @TheVFoundation @theNCI Congratulations 👏

[Lawrence Kazak @kazaklab]

It’s finally here! Check out our website for the Adipose Biology Conference: https://t.co/rTxrN1PH1O with @beaudrj & @sung4400, partnered with @SableSys! Amazing speakers.
Registration is now open!!

📍Montreal, Canada
📅Aug 19-20, 2025
#adiposebiology

[Lawrence Kazak @kazaklab]

I'm thrilled to co-organize the inaugural #AdiposeBiology Conference with @beaudrj, @sung4400, and @SableSys!

📍Montreal, Canada
📅Aug 19-20, 2025

Registration opens Jan 1, 2025. More info in the coming weeks.

Hope to see you there! @AdiposeBiology #AdiposeBiology2025

[Janane F. Rahbani @RahbaniLab]

@SvenssonLab @nbds_bio @StanfordPath @StanfordDRC Congratulations 👏

[Janane F. Rahbani @RahbaniLab]

@Z_GerhartHines @Nature Congratulations 👏

[Zach Gerhart-Hines @Z_GerhartHines]

Our new paper, "NK2R control of energy expenditure and feeding to treat metabolic diseases," is out today in @Nature.
Here we identify a single receptor that can both peripherally increase energy expenditure and centrally suppress appetite.
https://t.co/6Q8nG7wFOs

1/12 🧵👇

[Muir Lab @Muir_Lab]

Research Scientist position is open @ the UChicago Metabolomics Platform. Exciting position to work with cutting edge instrumentation to perform metabolomics, lipidomics and stable isotope tracing experiments! Please RT and forward onto anyone interested!

https://t.co/zxldUErvYn